ANGELA PATE: Open Payments
NPI 1386336493 · SOUTHSIDE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 62 payments from 18 companies in 2025. Trend: 2023 $114 · 2024 $676 · 2025 $1,303
Food & beverage: $1,203Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $301 |
| ABBVIE INC. | 9 | $182 |
| Astellas Pharma US Inc | 3 | $151 |
| Novo Nordisk Inc | 11 | $146 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| Corcept Therapeutics | 3 | $64 |
| PFIZER INC. | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Amgen Inc. | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
Products named: VRAYLAR, AIRSUPRA, Auvelity, BREZTRI, Korlym, FARXIGA, Ozempic, Veozah.
Industry payments across AL — which companies pay providers there.
